Journal Article Summary
The article investigates the interaction between simvastatin, a medication commonly used to lower cholesterol, and anacetrapib, a drug being developed to treat abnormal lipid levels by inhibiting cholesteryl ester transfer protein (CETP). Understanding how these two medications interact is important because they may be used together in patients with high cholesterol. The study aims to determine whether anacetrapib affects how simvastatin works in the body, which could have implications for treatment strategies in managing dyslipidemia.
In this study, twelve healthy participants were involved in a randomized, crossover trial where they received either simvastatin alone or simvastatin combined with anacetrapib over two treatment periods. Each treatment lasted for 14 days, with a wash-out period in between. The results showed that both treatment regimens were well tolerated, and there was no significant change in the levels of simvastatin in the body when taken with anacetrapib. However, the combination therapy resulted in a greater reduction in low-density lipoprotein cholesterol (LDL-C), indicating that anacetrapib may enhance the cholesterol-lowering effect of simvastatin.
Despite the positive findings, the study has limitations, including the small number of participants, which may affect the generalizability of the results. Patients should be aware that while the combination of these drugs appears safe and effective in this study, individual responses can vary. It is essential for readers to discuss any potential medication combinations with their healthcare providers to ensure safety and effectiveness in their specific health situations.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Krishna Rajesh, Garg Amit, Jin Bo, Keshavarz Sara Sadeghi, Bieberdorf Frederick A, Chodakewitz Jeffrey, Wagner John A. Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. British Journal of Clinical Pharmacology 2009. DOI: 10.1111/j.1365-2125.2009.03385.x. PMID: 19552746. PMCID: PMC2686068.
Featured Pill Pals Product
Simvastatin 10 mg Tablets --- Generic For Zocor --- Accord Pharma
Simvastatin 10 mg Tablets — Generic For Zocor — Accord Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
